High-potency cannabis study bypasses federal legalization research limits to test decision making, memory, and more

Your guide to cutting-edge methods in cannabis and cannabinoid analysis

Earlier this month, The Cannabis Scientist shared the 10 recommendations a number of experts made to the UK government

Without a uniform testing standard, US hemp industry participants will continue to face discriminatory penalties, federal scrutiny, and arrests

Find out what a phenotypic analysis of 300 plants from a hemp-BLMT cross tells us about leaf shape and THC/CBD profiles.

Medical cannabis is well tolerated – and improves sleep, functional wellbeing, and quality of life – in high-grade glioma patients

Comparative genomic analyses sheds light on origin of cannabinoid oxidocyclase genes, revealing a potential new classification system

Is Africa getting short-changed on its own resources by foreign cannabis companies?

Meet the Wizards of Oz in a mini tour of The Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney

Perhaps powered by an increasingly legal US market, the medical cannabis engine across the Atlantic appears to be (slowly) building momentum